Lon Smith is an Oncology physician affiliated with South Texas Accelerated Research Therapeutics. OpenAlex indexes 70 publications with 3,920 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4383 Medical Dr
San Antonio, TX 782293307
Telephone
210-593-5700Registry record last updated 11 Jul 2013.
Industry payments
32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year20259 payments
- AstraZeneca Pharmaceuticals LPProgram year20257 payments
- Lilly USA, LLCProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
88.8%RANK Ligand Inhibitor88.8%Denosumab100%Part B, office-administered≥17 patientsCancer & immunology
4.9%Aromatase Inhibitor1.5%Anastrozole90%Exemestane10%Part D<11 patientsEstrogen Agonist/Antagonist1.4%Tamoxifen Citrate100%Part D≥30 patients+ 4 more classes in this area
Nervous system
2.5%Benzodiazepine0.7%Lorazepam44%Alprazolam29%Clonazepam27%Part D<11 patientsSSRI0.6%Citalopram Hbr44%Fluoxetine Hcl28%Sertraline Hcl28%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1997–1997 per NIH RePORTER. The latest:
- PHASE I STUDY OF THE PHARMACOKINETICS OF VX-710
University of Texas Hlth Sci Ctr San Ant
FY1997M01RR001346
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”